---
figid: PMC4324736__BMRI2015-303791.003
figlink: /pmc/articles/PMC4324736/figure/fig3/
number: Figure 3
caption: The individual involvement of the products of the eight studied genes (shown
  in red colour) in the (a) RAS/RAF/MEK/MAPK, (b) PI3K/AKT, and (c) GNAQ/11 signalling
  transduction pathways. BRAF (shown in dark red colour) was the only gene found mutated
  in a single patient in our series. All three members of the RAS family of GTPases,
  that is, the HRAS, KRAS, and NRAS, function as regulated binary switches and, following
  growth factor stimulation via the receptor tyrosine kinase (RTK), bind and activate
  downstream effectors, mainly BRAF and PI3K, leading sequentially to the activation
  of the ERK and AKT kinases, operating in the two major signal transduction pathways,
  respectively. Additional pathways, such as the apoptosis pathway and the CDK pathway
  leading to cell cycle progression, can be further activated from these downstream
  effectors of the two major pathways. Upstream of RAS and PI3K, c-KIT can be also
  mutated or amplified in melanoma and in turn activate the downstream effectors of
  the two major pathways. An alternative pathway via the endothelin receptor (ETR),
  involving two heterotrimeric G-α-proteins, that is, GNAQ and GNA11, can also activate
  the BRAF/MEK/MAPK/ERK pathway and appears to be important for both normal melanocyte
  development and melanoma formation. Finally, MITF plays also an essential role in
  melanocyte-specific transcription, exhibiting multiple regulatory functions. mTOR,
  mammalian target of rapamycin; MITF, microphthalmia-associated transcription factor;
  TFs, transcription factors.
pmcid: PMC4324736
papertitle: Low Mutational Burden of Eight Genes Involved in the MAPK/ERK, PI3K/AKT,
  and GNAQ/11 Pathways in Female Genital Tract Primary Melanomas.
reftext: Kalliopi I. Pappa, et al. Biomed Res Int. 2015;2015:303791.
pmc_ranked_result_index: '14199'
pathway_score: 0.967752
filename: BMRI2015-303791.003.jpg
figtitle: Individual involvement of the products of the eight studied genes (shown
  in red colour) in the (a) RAS/RAF/MEK/MAPK, (b) PI3K/AKT, and (c) GNAQ/11 signalling
  transduction pathways
year: '2015'
organisms: Homo sapiens
ndex: 4c018023-decd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4324736__BMRI2015-303791.003.html
  '@type': Dataset
  description: The individual involvement of the products of the eight studied genes
    (shown in red colour) in the (a) RAS/RAF/MEK/MAPK, (b) PI3K/AKT, and (c) GNAQ/11
    signalling transduction pathways. BRAF (shown in dark red colour) was the only
    gene found mutated in a single patient in our series. All three members of the
    RAS family of GTPases, that is, the HRAS, KRAS, and NRAS, function as regulated
    binary switches and, following growth factor stimulation via the receptor tyrosine
    kinase (RTK), bind and activate downstream effectors, mainly BRAF and PI3K, leading
    sequentially to the activation of the ERK and AKT kinases, operating in the two
    major signal transduction pathways, respectively. Additional pathways, such as
    the apoptosis pathway and the CDK pathway leading to cell cycle progression, can
    be further activated from these downstream effectors of the two major pathways.
    Upstream of RAS and PI3K, c-KIT can be also mutated or amplified in melanoma and
    in turn activate the downstream effectors of the two major pathways. An alternative
    pathway via the endothelin receptor (ETR), involving two heterotrimeric G-α-proteins,
    that is, GNAQ and GNA11, can also activate the BRAF/MEK/MAPK/ERK pathway and appears
    to be important for both normal melanocyte development and melanoma formation.
    Finally, MITF plays also an essential role in melanocyte-specific transcription,
    exhibiting multiple regulatory functions. mTOR, mammalian target of rapamycin;
    MITF, microphthalmia-associated transcription factor; TFs, transcription factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK16
  - CDK12
  - PIK3CG
  - CDK17
  - CDK18
  - PIK3CD
  - CDKL3
  - MITF
  - PIK3R4
  - NRAS
  - PIK3CB
  - PIK3R6
  - MTOR
  - GNA11
  - PIK3CA
  - CDK9
  - CDK19
  - PIK3R3
  - PTEN
  - CDKL4
  - MAP2K2
  - BRAF
  - CDK1
  - CDK2
  - PDK1
  - CDK4
  - PIK3R5
  - GNAQ
  - HRAS
  - KRAS
  - CDK10
  - MAP2K1
  - CDKL1
  - CDKL2
  - CDK11B
  - KIT
  - MAPK3
  - MAPK1
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK11A
  - CDK20
  - AKT1
  - AKT2
  - BCL2L1
  - CDK14
  - CDK3
  - CDKL5
  - CDK13
  - CDK15
  - AKT3
  - Cancer
  - Lung cancer
  - Melanoma
genes:
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GNA11
  symbol: GNA11
  source: hgnc_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: -PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: GNAQ
  symbol: GNAQ
  source: hgnc_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: HRAS
  symbol: HRAS
  source: hgnc_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: c-KIT
  symbol: C-Kit
  source: hgnc_alias_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Bcl-xl
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
---
